Xiancheng Chen

1.5k citations
46 papers · 1.0k indexed · h-index 21
Topics
Immunotherapy and Immune Responses (10 papers)RNA Interference and Gene Delivery (9 papers)Cancer Cells and Metastasis (8 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Xiancheng Chen

45 papers receiving 1.0k citations

Peers

Xiancheng Chen
Comparison fields: 5 of 94
  • Molecular Biology 582
  • Oncology 249
  • Genetics 213
  • Cancer Research 186
  • Immunology 158
Replace Sally‐Anne Stephenson with:
Sally‐Anne Stephenson Australia
Karen A. Olson United States
Jian Yu China
Michal Shahar Israel
Marta Compte Spain
Ralph Francescone United States
Anthony Venida United States
Anna Darabi Sweden
Fatima Lekmine United States
Jeffrey D. McBride United States
Xiancheng Chen relative to Sally‐Anne Stephenson Australia Sally‐Anne Stephenson's profile →
Citations per field
00.5×1.5×1.8×
Sally‐Anne Stephenson · 1×
Citations per year

Countries citing papers authored by Xiancheng Chen

Since Specialization
Citations

This map shows the geographic impact of Xiancheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiancheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiancheng Chen more than expected).

Fields of papers citing papers by Xiancheng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiancheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiancheng Chen. The network helps show where Xiancheng Chen may publish in the future.

Co-authorship network of co-authors of Xiancheng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiancheng Chen. A scholar is included among the top collaborators of Xiancheng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiancheng Chen. Xiancheng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 1
3 2
4 11
5 1
6 22
7 19
8 31
9 26
10 12
11 32
12 25
13 2
14 49
15 12
16 26
17 3
18 6
19 17
20 35

About Xiancheng Chen

Xiancheng Chen is a scholar working on Microbiology, Genetics and Immunology, having authored 46 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), RNA Interference and Gene Delivery (9 papers) and Cancer Cells and Metastasis (8 papers). The work is most often cited by research in Genetics (213 citations), Microbiology (100 citations) and Cancer Research (186 citations). Xiancheng Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yuquan Wei, Xia Zhao, Yongsheng Wang, Bing Kan, Yanjun Wen, Xiaojuan Lin, Shi H, Yang Li, Lijuan Chen and Liangfu Zhou. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026